Shanxi Zhendong Pharmaceutical (300158) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million ≈ $-28.96 Million USD) by net assets (CN¥3.63 Billion ≈ $530.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanxi Zhendong Pharmaceutical market capitalisation for the company's overall valuation and market capitalisation.

Shanxi Zhendong Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency. Explore Shanxi Zhendong Pharmaceutical earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Chenguang Biotech Group SHE:300138	0.155x
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	N/A
HIVE Digital Technologies Ltd NASDAQ:HIVE	0.032x
Ardmore Shpng NYSE:ASC	0.041x
Sgis Songshan Co Ltd SHE:000717	0.093x
Zhe Jiang Kangsheng Co Ltd SHE:002418	-0.053x
Ganesh Housing Corporation Limited NSE:GANESHHOUC	0.199x
Worldline SA PA:WLN	0.032x

Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. View 300158 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.66 Billion ≈ $535.61 Million	CN¥-149.82 Million ≈ $-21.92 Million	-0.041x	-10.85%
2023-12-31	CN¥5.14 Billion ≈ $752.74 Million	CN¥-189.95 Million ≈ $-27.80 Million	-0.037x	-323.47%
2022-12-31	CN¥5.22 Billion ≈ $764.33 Million	CN¥86.31 Million ≈ $12.63 Million	0.017x	-53.21%
2021-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥284.45 Million ≈ $41.62 Million	0.035x	-10.36%
2020-12-31	CN¥5.63 Billion ≈ $824.31 Million	CN¥221.94 Million ≈ $32.48 Million	0.039x	+15.04%
2019-12-31	CN¥5.44 Billion ≈ $796.21 Million	CN¥186.35 Million ≈ $27.27 Million	0.034x	+18.89%
2018-12-31	CN¥5.36 Billion ≈ $784.69 Million	CN¥154.48 Million ≈ $22.60 Million	0.029x	+255.11%
2017-12-31	CN¥5.56 Billion ≈ $813.28 Million	CN¥45.09 Million ≈ $6.60 Million	0.008x	+195.63%
2016-12-31	CN¥5.27 Billion ≈ $771.41 Million	CN¥-44.72 Million ≈ $-6.54 Million	-0.008x	-111.34%
2015-12-31	CN¥2.03 Billion ≈ $297.12 Million	CN¥151.84 Million ≈ $22.22 Million	0.075x	+101.19%
2014-12-31	CN¥1.97 Billion ≈ $288.29 Million	CN¥73.23 Million ≈ $10.72 Million	0.037x	+197.00%
2013-12-31	CN¥1.96 Billion ≈ $286.56 Million	CN¥-75.04 Million ≈ $-10.98 Million	-0.038x	-138.43%
2012-12-31	CN¥1.90 Billion ≈ $277.96 Million	CN¥189.40 Million ≈ $27.72 Million	0.100x	+308.83%
2011-12-31	CN¥1.86 Billion ≈ $271.95 Million	CN¥-88.73 Million ≈ $-12.98 Million	-0.048x	-362.53%
2010-12-31	CN¥1.78 Billion ≈ $260.67 Million	CN¥32.40 Million ≈ $4.74 Million	0.018x	-84.54%
2009-12-31	CN¥359.31 Million ≈ $52.58 Million	CN¥42.28 Million ≈ $6.19 Million	0.118x	-5.43%
2008-12-31	CN¥266.72 Million ≈ $39.03 Million	CN¥33.18 Million ≈ $4.86 Million	0.124x	-82.94%
2007-12-31	CN¥176.42 Million ≈ $25.82 Million	CN¥128.65 Million ≈ $18.82 Million	0.729x	--

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic

Market Cap

$776.85 Million

CN¥5.31 Billion CNY

Market Cap Rank

#10116 Global

#2684 in China

Share Price

CN¥5.35

Change (1 day)

+3.28%

52-Week Range

CN¥4.57 - CN¥7.40

All Time High

CN¥12.00